RNXT
NASDAQ
$0.86
RenovoRx Inc (RNXT)
RenovoRx, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for the treatment of solid tumors. The company is headquartered in Los Altos, California.
Sector:
Healthcare
Industry:
Biotechnology
Buy
Target: $7.03 (+713.94%)
Market Cap
$39M
Free Cash Flow Yield
-29.18%
Beta (5Y)
0.85
Price Chart
Valuation
Market Cap$39M
P/S26.04
P/B3.37
Profitability
Total Revenue (TTM)$1.49M
Gross Profit (TTM)$1.17M
EBITDA-$11M
Operating Margin-616%
EPS-$0.32
Financial Health
Free Cash Flow Yield-29.18%
Growth & Risk
Beta (5Y)0.85
Sharpe Ratio-0.16